These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17098674)

  • 21. Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients.
    Besic N; Hocevar M; Zgajnar J; Pogacnik A; Grazio-Frkovic S; Auersperg M
    Langenbecks Arch Surg; 2005 Jun; 390(3):203-8. PubMed ID: 15599758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970.
    Gharib H; McConahey WM; Tiegs RD; Bergstralh EJ; Goellner JR; Grant CS; van Heerden JA; Sizemore GW; Hay ID
    Mayo Clin Proc; 1992 Oct; 67(10):934-40. PubMed ID: 1434853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis.
    Dandekar P; Harmer C; Barbachano Y; Rhys-Evans P; Harrington K; Nutting C; Newbold K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):518-21. PubMed ID: 19395202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaplastic cancer, lymphoma, and metastases of the thyroid gland.
    Pasieka JL
    Surg Oncol Clin N Am; 1998 Oct; 7(4):707-20. PubMed ID: 9735130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The combined treatment of anaplastic thyroid carcinoma].
    Serrano M; Monroy C; Rodríguez-García JL; País JR; Fernández-Garrido M
    An Med Interna; 1994 Jun; 11(6):288-90. PubMed ID: 7918941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
    Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
    Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anaplastic carcinoma of the thyroid. Our experience].
    Nicolosi A; Addis E; Massidda B; Malloci A; Mura E; Esu S
    Minerva Chir; 1992 Jul; 47(13-14):1161-7. PubMed ID: 1508369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival in anaplastic thyroid cancer.
    Schaefer CJ
    Md Med J; 1988 Nov; 37(11):873-4. PubMed ID: 3185160
    [No Abstract]   [Full Text] [Related]  

  • 29. Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery.
    Tennvall J; Tallroth E; el Hassan A; Lundell G; Akerman M; Biörklund A; Blomgren H; Löwhagen T; Wallin G
    Acta Oncol; 1990; 29(8):1025-8. PubMed ID: 2278722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery.
    Jpn J Clin Oncol; 1995 Oct; 25(5):203-7. PubMed ID: 7474408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
    Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid cancer: a multivariate analysis on influence of treatment on long-term survival.
    Staunton MD
    Eur J Surg Oncol; 1994 Dec; 20(6):613-21. PubMed ID: 7995409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteogenic anaplastic carcinoma of the thyroid.
    Pascal-Vigneron V; Schneegans O; Weryha G; Floquet J; Olivier P; Mayot D; Leclere J
    Thyroid; 1993; 3(4):319-23. PubMed ID: 8118226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canadian survey of thyroid cancer.
    Simpson WJ; McKinney SE
    Can Med Assoc J; 1985 Apr; 132(8):925-31. PubMed ID: 3978516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differential diagnosis and strategy for the treatment of anaplastic thyroid carcinoma].
    Suzuki S
    Nihon Rinsho; 2007 Nov; 65(11):2079-86. PubMed ID: 18018574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaplastic carcinoma of the thyroid: a 24-year experience.
    Tan RK; Finley RK; Driscoll D; Bakamjian V; Hicks WL; Shedd DP
    Head Neck; 1995; 17(1):41-7; discussion 47-8. PubMed ID: 7883548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplastic Carcinoma Thyroid - A Review on the Management of this Aggressive Cancer.
    Hussain SA; Subbiah S; Bharathiraja MS
    Gulf J Oncolog; 2018 Sep; 1(28):37-41. PubMed ID: 30344132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Undifferentiated carcinoma of the thyroid].
    Amodeo C; Caglià P; Gandolfo L; Veroux M; Donati M; Immè A
    Tumori; 2003; 89(4 Suppl):205-6. PubMed ID: 12903594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refining definitions within low-risk differentiated thyroid cancers.
    Nixon IJ; Simo RS; Kim D
    Clin Otolaryngol; 2018 Oct; 43(5):1195-1200. PubMed ID: 29770566
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaplastic (undifferentiated) thyroid cancer: improved insight and therapeutic strategy into a highly aggressive disease.
    O'Neill JP; O'Neill B; Condron C; Walsh M; Bouchier-Hayes D
    J Laryngol Otol; 2005 Aug; 119(8):585-91. PubMed ID: 16102210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.